Clinical Trials in Denver

Showing 3861-3880 of 18,161 trials

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

NCT05780034

This clinical trial is evaluating a drug called AC676 in participants with Relapsed/Refractory B-cell Malignancies. The main goals of the study are to: * Identify the recommended dose of AC676 that can be given safely to participants * Evaluate the safety profile of AC676 * Evaluate the pharmacokinetics of AC676 * Evaluate the effectiveness of AC676

Relapsed/Refractory B-cell Malignancies

Accutar Biotechnology Inc60 participantsStarted Jun 2023

Denver, Colorado, United States • Sarasota, Florida, United States • Chapel Hill, North Carolina, United States +6 more locations

RECRUITING< 1 mile

A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

NCT06504589

The REACH study is for people with CF who do not take cystic fibrosis transmembrane conductance regulator (CFTR) modulators. The goal of the REACH study is to collect research data, including health data and specimens, from people with CF who do not take CFTR modulators. This data may be used to inform CF research, help design CF clinical trials and support the development of new treatments for people with CF who do not take CFTR modulators. Another goal of this study is to learn about research involvement for people with CF who do not take CFTR modulators, engage them in research, and give them an opportunity to learn about what is involved in participating in a CF research study.

Cystic Fibrosis

Nicole Hamblett400 participantsStarted Sep 2024

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +65 more locations

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

Find Trials by Condition in Denver

Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis

A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A

Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer

Pembrolizumab With Chemotherapy and MK-4830 for Treating Participants With Ovarian Cancer (MK-4830-002)

A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer

Evaluation of Efficacy and Safety of VX-548 for Painful Lumbosacral Radiculopathy (PLSR)

First-in-human Study of Orally Administered KT-621 in Healthy Adult Participants

HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial

Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients

Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)

Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCC

A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.

Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer

Study With Various Immunotherapy Treatments in Participants With Lung Cancer

Surgeon-performed Ultrasound for Real-time Guidance In Oral Cancer Surgeries - A Multicenter Randomized Controlled Trial

Close Assessment and Testing for Chronic Graft Versus Host Disease, CATCH Study